AffyImmune Therapeutics scores $30m
AffyImmune Therapeutics Inc, a clinical stage biotechnology company, has raised $30 million in funding.
AffyImmune Therapeutics Inc, a clinical stage biotechnology company, has raised $30 million in funding.
Copyright PEI Media
Not for publication, email or dissemination